Chapter 59. Cutaneous Sarcoidosis

  1. Hywel Williams MSC, PhD, FRCP Professor Dermato-Epidemiology Co-ordinating Editor
  1. Leonid Izikson MD Resident in Dermatology and
  2. Joseph C. English III MD Associate Professor of Dermatology Residency Program Director

Published Online: 14 JAN 2009

DOI: 10.1002/9781444300161.ch59

Evidence-Based Dermatology, Second Edition

Evidence-Based Dermatology, Second Edition

How to Cite

Izikson, L. and English, J. C. (2008) Cutaneous Sarcoidosis, in Evidence-Based Dermatology, Second Edition (ed H. Williams), Blackwell Publishing Ltd., Oxford, UK. doi: 10.1002/9781444300161.ch59

Editor Information

  1. Centre of Evidence-Based Dermatology, Nottingham University Hospital NHS Trust, Queen's Medical Centre, Nottingham, UK

Author Information

  1. Department of Dermatology, University of Pittsburgh, Pittsburgh, USA

Publication History

  1. Published Online: 14 JAN 2009
  2. Published Print: 11 APR 2008

ISBN Information

Print ISBN: 9781405145183

Online ISBN: 9781444300161



  • cutaneous sarcoidosis;
  • sarcoidosis - systemic, idiopathic disease and noncaseating epithelioid granulomas;
  • oral glucocorticoids in systemic sarcoidosis;
  • drug-induced bullous pemphigoid;
  • methotrexate therapy complications and bonemarrow suppression;
  • thalidomide for cutaneous sarcoidosis and adverse peripheral neuropathy;
  • allopurinol therapy and drug rash;
  • Flashlamp pulsed-dye laser (fPDL) therapy in port-wine stains and telangiectasias;
  • phonophoresis - beneficial modality


This chapter contains sections titled:

  • Background

  • Questions

  • References